Investing
Arbutus files patent infringement lawsuit against Pfizer/BioNTech
© Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
(Reuters) -Arbutus Biopharma said on Tuesday it has filed a lawsuit in the New Jersey district court against Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:), claiming their mRNA COVID-19 vaccines infringe five of Arbutus’ patents.
Arbutus, along with its licensee Genevant Sciences, is seeking damages over the use of lipid nanoparticle (LNP) delivery technology in Pfizer/BioNTech vaccines to carry and deliver genetic material into the body.
Pfizer and BioNTech did not immediately respond to Reuters’ requests for comment on the lawsuit.
Shares of the Pennsylvania-based Arbutus rose marginally to $3.09 before the bell.
Read the full article here
10 Ways to Make Money As a Graphic Designer
Trump’s 2025 Inaugural Committee Raises Record $170 Million
Want to Build a Digital Business? Here’s the Framework You Need to Succeed.
Could Easier Cancellations Build Customer Loyalty?
How to Build Resilience, Stay Ahead of the Curve and Drive Growth in 2025
Moldova breakaway region to face new power cuts on Saturday, officials say By Reuters
Reebok Co-Founder Backs Syntilay’s New AI, 3D-Printed Shoe
How to Survive High-Demand Seasons Without Losing Customers
5 Things That Could Significantly Impact Your Company in 2025
NFI Group surge after board reshaped with new appointments, chairperson By Investing.com
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Investing6 days agoMoldova breakaway region to face new power cuts on Saturday, officials say By Reuters
-
Investing6 days agoReebok Co-Founder Backs Syntilay’s New AI, 3D-Printed Shoe
-
Side Hustles6 days agoHow to Survive High-Demand Seasons Without Losing Customers
-
Side Hustles4 days ago5 Things That Could Significantly Impact Your Company in 2025
-
Investing4 days agoNFI Group surge after board reshaped with new appointments, chairperson By Investing.com
-
Side Hustles6 days agoShake It Up — Dunkin’ Debuts Star-Backed Winter Menu
-
Make Money6 days ago9 Easy Steps to Begin Your Gold Investment Journey
-
Side Hustles5 days agoHow Failing 22 Times Paved the Way to My Success